Baxion
Screening
Tags
Alerts
Theme
XTL Biopharmaceuticals Ltd.
XTLB
·
NASDAQ
·
$2.38
Share Price as of 11/2
·
$6M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
20-F
Annual report (foreign)
06/30/26
20-F
Annual report (foreign)
04/30/25
20-F
Annual report (foreign)
04/30/24
20-F
Annual report (foreign)
03/22/23
20-F
Annual report (foreign)
03/30/22
Disclosures
Filter
6-K
Foreign issuer report
10/14/26
6-K
Foreign issuer report
08/05/26
6-K
Foreign issuer report
07/21/26
6-K
Foreign issuer report
06/30/26
6-K
Foreign issuer report
06/29/26
Prospectuses and Registrations
Filter
424B3
Prospectus
06/09/21
POS AM
Post-effective amendment
06/02/21
424B3
Prospectus
03/07/18
F-1/A
Registration (foreign issuer, amended)
02/28/18
F-1/A
Registration (foreign issuer, amended)
02/01/18
Proxies
Filter
No matching filings.
Ownership
Filter
Form 3
Initial insider ownership
03/23/26
Form 3
Initial insider ownership
03/23/26
SC 13G/A
Beneficial ownership (amended)
01/05/18
SC 13G
Beneficial ownership
02/27/17
SC 13G/A
Beneficial ownership (amended)
01/06/17
Other
Filter
NT 20-F
Late filing notification (20-F)
04/30/26
EFFECT
Request for effectiveness
06/07/21
EFFECT
Request for effectiveness
03/06/18
CORRESP
Correspondence with the SEC
03/02/18
D
D
03/29/17
Latest Filings
Filter
6-K
Foreign issuer report
10/14/26
6-K
Foreign issuer report
08/05/26
6-K
Foreign issuer report
07/21/26
20-F
Annual report (foreign)
06/30/26
6-K
Foreign issuer report
06/30/26
Ownership
Filter
Form 3
Initial insider ownership
03/23/26
Form 3
Initial insider ownership
03/23/26
SC 13G/A
Beneficial ownership (amended)
01/05/18
SC 13G
Beneficial ownership
02/27/17
SC 13G/A
Beneficial ownership (amended)
01/06/17